X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
non-hodgkins-lymphoma (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
chemotherapy (3) 3
cyclophosphamide - administration & dosage (3) 3
doxorubicin - administration & dosage (3) 3
female (3) 3
humans (3) 3
male (3) 3
middle aged (3) 3
prednisone - administration & dosage (3) 3
adolescent (2) 2
adult (2) 2
bleomycin - administration & dosage (2) 2
disease-free survival (2) 2
health aspects (2) 2
lymphomas (2) 2
management (2) 2
medicine, general & internal (2) 2
neoplasm staging (2) 2
survival analysis (2) 2
survival rate (2) 2
treatment outcome (2) 2
vincristine - administration & dosage (2) 2
vindesine - administration & dosage (2) 2
adults (1) 1
age factors (1) 1
aged (1) 1
aged, 80 and over (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - pharmacology (1) 1
antibodies, monoclonal, murine-derived (1) 1
antineoplastic combined chemotherapy protocols - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis (1) 1
bcl-2 (1) 1
blood cells - metabolism (1) 1
blood cells - pathology (1) 1
bone marrow (1) 1
bone-marrow-transplantation (1) 1
brief chemotherapy (1) 1
cancer (1) 1
cancer therapies (1) 1
care and treatment (1) 1
cell transplantation (1) 1
chop chemotherapy (1) 1
colony-stimulating factor (1) 1
combination (1) 1
combined modality therapy (1) 1
confidence intervals (1) 1
cyclophosphamide (1) 1
cyclophosphamide - pharmacology (1) 1
cytotoxicity (1) 1
doxorubicin (1) 1
doxorubicin - pharmacology (1) 1
drug resistance, neoplasm - drug effects (1) 1
fatigue (1) 1
follow-up studies (1) 1
gene expression regulation, neoplastic - drug effects (1) 1
genes, bcl-2 (1) 1
grade (1) 1
hematology (1) 1
hematopoietic stem cell transplantation (1) 1
hepatitis (1) 1
immunotherapy (1) 1
intensive chemotherapy (1) 1
interferon (1) 1
interferon alpha (1) 1
large-cell lymphoma (1) 1
leukemia (1) 1
leukocytes (1) 1
limited-stage (1) 1
low-grade (1) 1
lymphoma (1) 1
lymphoma - mortality (1) 1
lymphoma - pathology (1) 1
lymphoma - therapy (1) 1
lymphoma, large b-cell, diffuse - drug therapy (1) 1
lymphoma, large b-cell, diffuse - mortality (1) 1
lymphoma, non-hodgkin - drug therapy (1) 1
lymphoma, non-hodgkin - pathology (1) 1
lymphoma, non-hodgkin - radiotherapy (1) 1
medical prognosis (1) 1
medical treatment (1) 1
multicenter studies as topic - statistics & numerical data (1) 1
multivariate analysis (1) 1
neoplasm proteins - genetics (1) 1
neoplasm proteins - physiology (1) 1
non-hodgkin's lymphoma (1) 1
non-hodgkin's lymphomas (1) 1
oncology (1) 1
phase-iii (1) 1
prednisone (1) 1
prednisone - pharmacology (1) 1
prognosis (1) 1
prognostic factors (1) 1
proportional hazards models (1) 1
proto-oncogene proteins c-bcl-2 - physiology (1) 1
r-chop (1) 1
radiation (1) 1
radiotherapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2005, Volume 352, Issue 12, pp. 1197 - 1205
Journal Article
Haematologica, ISSN 0390-6078, 05/2006, Volume 91, Issue 5, pp. 715 - 716
Rituximab plus CHOP (R-CHOP) has been proven to increase overall survival in aggressive bcl-2-positive lymphoma patients. Using competing risk analysis, we... 
APOPTOSIS | bcl-2 | survival analysis | SENSITIZATION | R-CHOP | lymphoma | NON-HODGKINS-LYMPHOMA | HEMATOLOGY | rituximab | CHEMOTHERAPY | Vincristine - pharmacology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Proto-Oncogene Proteins c-bcl-2 - physiology | Age Factors | Humans | Middle Aged | Neoplasm Proteins - physiology | Male | Risk | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Immunotherapy | Aged, 80 and over | Vincristine - administration & dosage | Female | Gene Expression Regulation, Neoplastic - drug effects | Neoplasm Proteins - genetics | Doxorubicin - administration & dosage | Multicenter Studies as Topic - statistics & numerical data | Prednisone - administration & dosage | Randomized Controlled Trials as Topic - statistics & numerical data | Antibodies, Monoclonal, Murine-Derived | Lymphoma, Large B-Cell, Diffuse - drug therapy | Antibodies, Monoclonal - pharmacology | Proportional Hazards Models | Rituximab | Genes, bcl-2 | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Cyclophosphamide - pharmacology | Survival Analysis | Prednisone - pharmacology | Aged | Doxorubicin - pharmacology | Drug Resistance, Neoplasm - drug effects | Survival analysis | Lymphoma
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.